| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301972C Piperidine compounds as muscarinic antagonists |
| 02/28/2007 | CN1301970C 2,4-substituted indoles and their use as 5-HT6 modulators |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301950C Novel vitamin D analogues |
| 02/28/2007 | CN1301751C Infection-resistant medical devices |
| 02/28/2007 | CN1301727C Externally applied Chinese medicine preparation for treating skin disease and its preparation method |
| 02/28/2007 | CN1301722C Sow thistle extract, preparing process and application thereof |
| 02/28/2007 | CN1301719C Quick-acting decoction for treating burns and scald |
| 02/28/2007 | CN1301718C Extraction for radix cynanchi bungei polysaccharide and oral lozenge preparation |
| 02/28/2007 | CN1301717C Inclusion compound of glycyrrhizic acid or its derivative and alkaloid, and its preparation method |
| 02/28/2007 | CN1301716C Slow-releasing Benproperine phosphate dripping pill and its prepn process |
| 02/28/2007 | CN1301715C Pregnenolone in steroid species and isomeric compound in application of preparing medicaton for treating high blood pressure |
| 02/28/2007 | CN1301714C Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| 02/28/2007 | CN1301713C Stephanine soft capsule, and its preparation method |
| 02/28/2007 | CN1301712C Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties |
| 02/28/2007 | CN1301711C Use of vegetable flavonoid |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CN1301709C Skin plaster containing aceclofenac |
| 02/28/2007 | CN1301708C Orally administrable composition for the photoprotection of the skin |
| 02/28/2007 | CN1301706C Pharmaceutical composition for sustained or continuous releasing therapeutic active components |
| 02/28/2007 | CN1301660C Method for supplying bioavailable methionine to cow |
| 02/27/2007 | USRE39497 Storage of materials |
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183430 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same |
| 02/27/2007 | US7183416 Polymorph of a pharmaceutical |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183414 Processes for the preparation of benzoimidazole derivatives |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution |
| 02/27/2007 | US7183324 2,3,4-substituted cyclopentanones as therapeutic agents |
| 02/27/2007 | US7183322 Remedy for hypertension |
| 02/27/2007 | US7183321 Antidiabetic formulation and method |
| 02/27/2007 | US7183320 For therapy of neoplastic diseases |
| 02/27/2007 | US7183319 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183317 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 02/27/2007 | US7183316 Treatment of HPV caused diseases |
| 02/27/2007 | US7183315 Therapeutic agent for use in tissue repair; wound healing agents; bactericides; fungicides |
| 02/27/2007 | US7183314 Compound for treatment of anxiety and methods of preparation and use thereof |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183310 Compounds for prodrug for bonding, using prostaglandins |
| 02/27/2007 | US7183309 Indole derivatives useful as progesterone receptor modulators |
| 02/27/2007 | US7183308 Multistage process for forming perindopril from acid compound |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183306 Pyrazole derivatives |
| 02/27/2007 | US7183305 Reaction of cyano compound with silylalkylisocyanide for active imidazoles |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183302 Iminothiazolidinones as inhibitors of HCV replication |
| 02/27/2007 | US7183301 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 02/27/2007 | US7183300 Compounds that inhibit Hiv formation for viricides and inhibition of capsid formation |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/27/2007 | US7183294 Indole derivatives useful for the treatment of diseases |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183292 Substituted pyrrolidine and related compounds |
| 02/27/2007 | US7183291 Method for the treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183289 39-desmethoxyrapamycin, compositions and methods of use thereof |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183287 Substituted pyrimidinones |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183285 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| 02/27/2007 | US7183284 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 02/27/2007 | US7183283 5-{2-[4-[1-(4-fluoro-2-hydroxy-phenyl)-methanoyl]-piperidine-1-yl]-(ethyl or propyl)amino}-(optional 2-alkyl)-2H-pyridazine-3-one; hydrogenation of the isoxazolyl-alkylamino-pyridazinone; anxiolytic agents |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183280 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 02/27/2007 | US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183272 Crystal forms of oxcarbazepine and processes for their preparation |
| 02/27/2007 | US7183271 Vasopressin active materials; antidiabetic agents; diuretics; bioavailability |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183269 Using benzoic acid compounds; anticancer compound |
| 02/27/2007 | US7183268 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents |
| 02/27/2007 | US7183267 Bis[(dihydroxyborylphenyl)carbonyloxy]benzenes may be synergistically combined with beta-lactam antibiotics to treat beta-lactam antibiotic resistant bacterial infections |
| 02/27/2007 | US7183266 Dual induced viscosity fiber system and uses thereof |
| 02/27/2007 | US7183265 Powdery product comprising crystalline β-maltose monohydrate, its preparation, and uses |
| 02/27/2007 | US7183264 Such as ethyl-1-(9-((4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxy-methyl)oxolan-2-yl)-6 -aminopurin-2-yl)pyrazole-4-carboxylate; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 02/27/2007 | US7183263 protein expression levels higher than linear polyethylenimine alone, and twice that of branched polyethylenimine, but without any significant loss in cell viability; sterols such as cholesterol conjugated via the haloformate ester reaction |
| 02/27/2007 | US7183261 Galactosylceramide analogs, and β-glucocerebrosidase activators, external skin preparations and method of activating β-glucocerebrosidase using the analogs |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |